EUVIMEDEUVIMED entdecken
Crossref

Proteomics and metabolomics in cancer biomarker discovery

Rinki Basoya, Nidhi Bhasin, Preeti Jain, Sadhna Aggarwal

Methods in Cell Biology · 2025

DOI: 10.1016/bs.mcb.2025.02.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Cell Biology, 2025. Verfasst von Rinki Basoya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genomics and Integrative Biotechnology, Mathura Road, New Delhi, India. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Metabolomics, Neoplasms, Proteomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer biomarker discovery is crucial for early diagnosis, prognosis, and therapeutic monitoring, and proteomics and metabolomics have emerged as powerful tools in biomarker research. Proteomics, the large-scale study of proteins, provides insights into the complex molecular changes that occur in cancer cells, offering potential biomarkers for tumor identification and monitoring treatment responses. Through techniques such as mass spectrometry and protein microarrays, proteomic analysis can identify differential protein expression, post-translational modifications, and protein-protein interactions that characterize different cancer stages. Similarly, metabolomics, the comprehensive analysis of small molecule metabolites, enables the identification of metabolic alterations associated with cancer. Tumor cells often exhibit reprogrammed metabolic pathways to sustain growth, making metabolites valuable as biomarkers for early cancer detection and treatment stratification. Both omics approaches allow for the identification of cancer-specific signatures, uncovering potential biomarkers with clinical relevance. This chapter describes the different proteomics and metabolomics techniques which are used in cancer biomarker discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorMetabolomicsNeoplasmsProteomicsHumansMass Spectrometry

Stichwörter der Autor:innen

Biomarker discoveryCancer biomarkersData analysisHPLCMass-spectrometryMetabolomicsNMRProteomicsTargeted MetabolomicsTissue MicroarrayUntargeted Metabolomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Institute of Genomics and Integrative Biotechnology, Mathura Road, New Delhi, India.
  • National Institute of Immunology, New Delhi, India.
  • Department of Life Sciences, Faculty of Sciences, Somaiya Vidyavihar University, Mumbai, India.
  • Department of Radiation Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States. Electronic address: micro9sadhna@gmail.com.

Zitieren

APA

Basoya, R., Bhasin, N., Jain, P., & Aggarwal, S. (2025). Proteomics and metabolomics in cancer biomarker discovery. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2025.02.010

Vancouver

Basoya R, Bhasin N, Jain P, Aggarwal S. Proteomics and metabolomics in cancer biomarker discovery. Methods in Cell Biology. 2025. doi:10.1016/bs.mcb.2025.02.010

BibTeX
@article{Basoya2025,
  author = {Basoya, Rinki and Bhasin, Nidhi and Jain, Preeti and Aggarwal, Sadhna},
  title = {Proteomics and metabolomics in cancer biomarker discovery},
  journal = {Methods in Cell Biology},
  year = {2025},
  doi = {10.1016/bs.mcb.2025.02.010}
}
Kostenlos starten →